The anti-CMS technique for genome-wide mapping of 5-hydroxymethylcytosine

Nature Protocols

Volumn 7, Issue 10, 2012, Pages 1897-1908

  Huang, Yun ^a   Pastor, William A ^a   Zepeda Martínez, Jorge A ^b   Rao, Anjana ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b INSTITUTO DE CIENCIAS FÍSICAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; ANTISERUM; CYTOSINE 5 METHYLENESULFONATE; DNA FRAGMENT; GENOMIC DNA; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; CLINICAL PROTOCOL; DEMETHYLATION; EXPERIMENTAL DESIGN; GENE EXPRESSION; GENE MAPPING; GENOME ANALYSIS; IMMUNOPRECIPITATION; OXIDATION; PRIORITY JOURNAL;

ANTIBODIES; BASE SEQUENCE; CYTOSINE; DNA PRIMERS; GENOMICS; IMMUNOPRECIPITATION; MOLECULAR SEQUENCE DATA; SULFITES;

MAMMALIA;

EID: 84869075314     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2012.103     Document Type: Article

References (43)

1. Li, Y. & Sasaki, H. Genomic imprinting in mammals: its life cycle, molecular mechanisms and reprogramming. Cell Res. 21, 466-473 (2011).
2. Jackson-Grusby, L. et al. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat. Genet. 27, 31-39 (2001).
3. Walsh, C.P., Chaillet, J.R. & Bestor, T.H. Transcription of IAP endogenous retroviruses is constrained by cytosine methylation. Nat. Genet 20, 116-117 (1998).
4. Bourc'his, D. & Bestor, T.H. Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature 431, 96-99 (2004).
5. Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935 (2009).
6. Ito, S. et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specifcation. Nature 466, 1129-1133 (2010).
7. Kriaucionis, S. & Heintz, N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324, 929-930 (2009).
8. Munzel, M. et al. Quantifcation of the sixth DNA base hydroxymethylcytosine in the brain. Angew. Chem. Int. Ed. Engl. 49, 5375-5377 (2010).
9. Ito, S. et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333, 1300-1303 (2011).
10. Valinluck, V. & Sowers, L.C. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res. 67, 946-950 (2007).
11. Valinluck, V. et al. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 32, 4100-4108 (2004).
12. Jin, S.G., Kadam, S. & Pfeifer, G.P. Examination of the specifcity of DNA methylation profling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res. 38, e125 (2010).
13. Pfaffeneder, T. et al. The discovery of 5-formylcytosine in embryonic stem cell DNA. Angew. Chem. Int. Ed. Engl. 50, 7008-7012 (2011).
14. He, Y.F. et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333, 1303-1307 (2011).
15. Maiti, A. & Drohat, A.C. Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites. J. Biol. Chem. 286, 35334-35338 (2011).
16. Koh, K.P. et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specifcation in mouse embryonic stem cells. Cell Stem Cell 8, 200-213 (2011).
17. Bacher, U. et al. Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies. Ann. Hematol. 89, 643-652 (2010).
18. Quivoron, C. et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 20, 25-38 (2011).
19. Moran-Crusio, K. et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 20, 11-24 (2011).
20. Li, Z. et al. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood 118, 4509-4518 (2011).
21. Ko, M. et al. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Proc. Natl. Acad. Sci. USA 108, 14566-14571 (2011).
22. Ko, M. et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 468, 839-843 (2010).
23. Haffner, M.C. et al. Global 5-hydroxymethylcytosine content is signifcantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget. 2, 627-637 (2011).
24. Wossidlo, M. et al. 5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming. Nat. Commun. 2, 241 (2011).
25. Gu, T.P. et al. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 477, 606-610 (2011).
26. Pastor, W.A., Huang, Y., Henderson, H.R., Agarwal, S. & Rao, A. The GLIB technique for mapping 5-hydroxymethylcytosine. Nat. Protoc. 7, 1909-1917 (2012).
27. Pastor, W.A. et al. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 473, 394-397 (2011).
28. Hayatsu, H., Wataya, Y., Kai, K. & Iida, S. Reaction of sodium bisulfte with uracil, cytosine, and their derivatives. Biochemistry 9, 2858-2865 (1970).
29. Hayatsu, H. & Shiragami, M. Reaction of bisulfte with the 5-hydroxymethyl group in pyrimidines and in phage DNAs. Biochemistry 18, 632-637 (1979).
30. Frommer, M. et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA 89, 1827-1831 (1992).
31. Huang, Y. et al. The behaviour of 5-hydroxymethylcytosine in bisulfte sequencing. PLoS ONE 5, e8888 (2010).
32. Weber, M. et al. Chromosome-wide and promoter-specifc analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet. 37, 853-862 (2005).
33. Zemach, A., McDaniel, I.E., Silva, P. & Zilberman, D. Genome-wide evolutionary analysis of eukaryotic DNA methylation. Science 328, 916-919 (2010).
34. Wu, H. et al. Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev. 25, 679-684 (2011).
35. Williams, K. et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fdelity. Nature 473, 343-348 (2011).
36. Ficz, G. et al. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473, 398-402 (2011).
37. Xu, Y. et al. Genome-wide regulation of 5hm C, 5m C, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol. Cell 42, 451-464 (2011).
38. Matarese, F., Carrillo-de Santa Pau, E. & Stunnenberg, H.G. 5-Hydroxymethylcytosine: a new kid on the epigenetic block? Mol. Syst. Biol. 7, 562 (2011).
39. Booth, M.J. et al. Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science 336, 934-937 (2012).
40. Song, C.X. et al. Sensitive and specifc single-molecule sequencing of 5-hydroxymethylcytosine. Nat. Methods 9, 75-77 (2012).
41. Yu, M. et al. Base-resolution analysis of 5-hydroxymethylcytosine in the Mammalian genome. Cell 149, 1368-1380 (2012).
42. Kornberg, S.R., Zimmerman, S.B. & Kornberg, A. Glucosylation of deoxyribonucleic acid by enzymes from bacteriophage-infected Escherichia coli. J. Biol. Chem. 236, 1487-1493 (1961).
43. Lister, R. et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462, 315-322 (2009).